Kolexia
Carenco Christophe
Gastro-entérologie
Ch Lezignan Corbieres
Lézignan-Corbières, France
29 Activités
3 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Obésité Hépatite Transformation cellulaire néoplasique Maladies du foie Hépatite C chronique Hépatite C Tumeurs colorectales Infections à virus oncogènes

Industries

Servier
3 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Sequential treatment with Nab-paclitaxel plus Gemcitabine and Folfirinox in metastatic pancreatic adenocarcinoma: GABRINOX phase II results.
2018 ASCO Annual Meeting I   01 juin 2018
Solid, non-skin, post-liver transplant tumors: Key role of lifestyle and immunosuppression management.
World journal of gastroenterology   17 janvier 2017
Gabrinox: A phase I-II of nab-paclitaxel plus gemcitabine followed by folfirinox in metastatic pancreatic adenocarcinoma
Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmark   01 octobre 2016
Gabrinox: A phase I-II of nab-paclitaxel plus gemcitabine followed by FOLFIRINOX in metastatic pancreatic adenocarcinoma.
2016 ASCO Annual Meeting I   20 mai 2016
Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons   03 février 2015
Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors.
Liver international : official journal of the International Association for the Study of the Liver   21 janvier 2015
Reply to: "Are Hedgehog and Wnt/β-catenin pathways involved in hepatitis C virus-mediated EMT?": persistent activation of Hedgehog or Wnt/β-catenin pathways is not involved in EMT mediated by HCV NS5A protein.
Journal of hepatology   28 novembre 2012
Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirin.
Antiviral therapy   18 mai 2012
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}